Journal article
Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro
Journal of Pharmacology and Experimental Therapeutics, Vol.310(1), pp.209-214
2004
Abstract
Human urotensin-II (hU-II) is processed from its prohormone (ProhU-II) at putative cleavage sites for furin and serine proteases such as trypsin. Although proteolysis is required for biological activity, the endogenous "urotensin-converting enzyme" (UCE) has not been investigated. The aim of this study was to investigate UCE activity in cultured human cells and in blood, comparing activity with that of furin and trypsin. In a cell-free system, hU-II was detected by high-performance liquid chromatography-mass spectrometry after coincubating 10 µM carboxyl terminal fragment (CTF)-ProhU-II with recombinant furin (2 U/ml, 3 h, 37°C) at pH 7.0 and pH 8.5, but not at pH 5.0, or when the incubating medium was depleted of Ca2+ ions and supplemented with 2 mM EDTA at pH 7.0. hU-II was readily detected in the superperfusate of permeabilized epicardial mesothelial cells incubated with CTF-ProhU-II (3 h, 37°C), but it was only weakly detected in the superperfusate of intact cells. Conversion of CTF-ProhU-II to hU-II was attenuated in permeabilized cells using conditions found to inhibit furin activity. In a cell-free system, trypsin (0.05 mg/ml) cleaved CTF-ProhU-II to hU-II, and this was inhibited with 35 µM aprotinin. hU-II was detected in blood samples incubated with CTF-ProhU-II (3 h, 37°C), and this was also inhibited with aprotinin. The findings revealed an intracellular UCE in human epicardial mesothelial cells with furin-like activity. Aprotinin-sensitive UCE activity was detected in blood, suggesting that an endogenous serine protease such as trypsin may also contribute to proteolysis of hU-II prohormone, if the prohormone is secreted into the circulation.
Details
- Title
- Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro
- Authors
- Fraser D Russell (Author) - University of QueenslandP Kearns (Author) - University of QueenslandI Toth (Author) - University of QueenslandP Molenaar (Author) - University of Queensland
- Publication details
- Journal of Pharmacology and Experimental Therapeutics, Vol.310(1), pp.209-214
- Publisher
- American Society for Pharmacology and Experimental Therapeutics
- Date published
- 2004
- DOI
- 10.1124/jpet.104.065425
- ISSN
- 0022-3565
- Organisation Unit
- School of Health - Biomedicine; University of the Sunshine Coast, Queensland; School of Health and Sport Sciences - Legacy; Centre for Bioinnovation; School of Health and Behavioural Sciences - Legacy
- Language
- English
- Record Identifier
- 99450271302621
- Output Type
- Journal article
Metrics
1 File views/ downloads
561 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Web Of Science research areas
- Pharmacology & Pharmacy
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites